Xytronyx Inc. reported a $195,994 loss on...

Xytronyx Inc. reported a $195,994 loss on $304,971 revenue for the second quarter ended Sept. 30, compared to a $286,040 loss on revenue of $23,135 over the same quarter a year ago. For the six months, the company posted a loss of $662,426 on revenue of $319,003, compared to a loss of $680,882 on revenue of $52,989 over the same period last year.

Xytronyx recently sold worldwide distribution and market rights to its periodontal disease test product to Colgate Palmolive.